Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
4G Clinical
AddedFeb 13, 2024
UpdatedJun 18, 2026
4G Clinical

4G Clinical

Late Stage Private

4G Clinical: Rapid, flexible healthcare tech for Pharma & CROs, specializing in RTSM solutions.

HQ
Wellesley, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees

4G Clinical's mission is to accelerate clinical trials by providing rapid, flexible, and validated randomization and trial supply management (RTSM) solutions. They cater primarily to pharmaceutical companies and contract research organizations (CROs), offering advanced healthcare technology designed to streamline and enhance the efficiency of clinical trials.

4G Clinical has achieved significant milestones in the healthcare technology sector, known for delivering RTSM capabilities faster than competitors. Their innovative solutions have made a substantial impact on the speed and flexibility of clinical trials, benefiting both the pharmaceutical industry and patients awaiting new treatments.

4G Clinical - Similar Companies

Atreo logo

Atreo

atreo.io

Endpoint Clinical logo

Endpoint Clinical

Clinical.Ly logo

Clinical.Ly

clinical.ly

Clinical Research IO logo

Clinical Research IO

iClinical logo

iClinical

Algorics logo

Algorics

Strategikon Pharma logo

Strategikon Pharma

ClinOne logo

ClinOne

clinone.com

Korio logo

Korio

korioclinical.com

ObvioHealth logo

ObvioHealth

obviohealth.com

TrialSpark logo

TrialSpark

trialspark.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

Curavit Clinical Research logo

Curavit Clinical Research

RxE2 logo

RxE2

rxe2.com

Medable logo

Medable

medable.com

4G Clinical - Quick Facts

Who are 4G Clinical's competitors?

Companies similar to 4G Clinical include Atreo, Endpoint Clinical, Clinical.Ly and Clinical Research IO.

When was 4G Clinical founded?

4G Clinical was founded in 2015.

Where is 4G Clinical's headquarters located?

4G Clinical's headquarters is located in Wellesley, MA, US.

When was 4G Clinical's last funding round?

4G Clinical's most recent funding round was for $230M (USD) in June 2021.

How much has 4G Clinical raised to-date?

As of Jun 29, 2021, 4G Clinical has raised a total of $252.1M (USD).

How many employees does 4G Clinical have?

4G Clinical has 396 employees as of Feb 5, 2024.

4G Clinical - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Cloud
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare
  • RTSM
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software